Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-06 Purchase | 2022-07-08 6:00 pm | TITAN PHARMACEUTICALS INC | TTNP | Lazar David E. Activist Investing LLC 10% Owner | 2,226,190 | $0.86375 | $1,922,882 | 3,690,468 (Indirect Direct) | View |
| 2018-10-19 Purchase | 2018-10-22 4:38 pm | TITAN PHARMACEUTICALS INC | TTNP | Recli Federico Seghi Director | 200,000 | $0 | $0 | 800,845 (Direct) | View |
| 2018-09-24 Purchase | 2018-09-26 5:45 pm | TITAN PHARMACEUTICALS INC | TTNP | Recli Federico Seghi Director | 500,000 | $0 | $0 | 600,845 (Direct) | View |
| 2018-09-21 Purchase | 2018-09-25 7:09 pm | TITAN PHARMACEUTICALS INC | TTNP.OB | MACFARLANE M DAVID Director | 80,000 | $0.25 | $20,000 | 182,275 (Direct) | View |
| 2018-09-21 Purchase | 2018-09-25 7:06 pm | TITAN PHARMACEUTICALS INC | TTP | BHONSLE SUNIL See Remarks | 300,000 | $0.25 | $75,000 | 790,262 (Indirect Direct) | View |
| 2018-09-21 Purchase | 2018-09-25 7:04 pm | TITAN PHARMACEUTICALS INC | TTNP | MCNAB JAMES R Director | 200,000 | $0.25 | $50,000 | 500,000 (Direct) | View |
| 2018-09-21 Purchase | 2018-09-25 7:02 pm | TITAN PHARMACEUTICALS INC | TTNP | Rubin Marc Chairman | 400,000 | $0.25 | $100,000 | 956,317 (Direct) | View |
| 2018-09-21 Purchase | 2018-09-25 7:00 pm | TITAN PHARMACEUTICALS INC | TTNP | Akers Joseph A Director | 200,000 | $0.25 | $50,000 | 413,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-15 Ownership | 2022-08-30 4:02 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | Ben-Tzvi Avraham Director | 0 | $0 | 0 (Direct) | View |
| 2022-08-15 Ownership | 2022-08-25 4:19 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | McMurdo Matthew Charles Director | 0 | $0 | 0 (Direct) | View |
| 2022-08-15 Ownership | 2022-08-25 4:19 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | Greenberg Eric Howard Director | 0 | $0 | 0 (Direct) | View |
| 2022-08-15 Ownership | 2022-08-25 4:19 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | NATAN DAVID Director | 0 | $0 | 0 (Direct) | View |
| 2022-08-15 Ownership | 2022-08-25 4:19 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | Chasey Peter Louis Director | 0 | $0 | 0 (Direct) | View |
| 2022-07-06 Ownership | 2022-07-08 6:00 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | Lazar David E. Activist Investing LLC 10% Owner | 0 | $0 | 1,464,278 (Direct) | View |
| 2022-01-28 Other | 2022-01-28 3:14 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | MCNAB JAMES R Director | 51,021 | $0 | 103,711 (Indirect) | View |
| 2022-01-05 Option Award | 2022-01-05 6:54 pm | 2022-07-05 2032-01-05 | TITAN PHARMACEUTICALS INC | TTNP | Akers Joseph A Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-01-05 Option Award | 2022-01-05 6:53 pm | 2022-07-05 2032-01-05 | TITAN PHARMACEUTICALS INC | TTNP.OB | MACFARLANE M DAVID Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-01-05 Option Award | 2022-01-05 6:52 pm | 2022-07-05 2032-01-05 | TITAN PHARMACEUTICALS INC | TTNP | MCNAB JAMES R Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-01-05 Option Award | 2022-01-05 6:50 pm | N/A 2032-01-05 | TITAN PHARMACEUTICALS INC | TTNP | Beebe Katherine COO | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-01-05 Option Award | 2022-01-05 6:48 pm | N/A 2032-01-05 | TITAN PHARMACEUTICALS INC | TTNP | Rubin Marc Chairman | 65,000 | $0 | 65,000 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-11 06:37 am | N/A 2031-02-10 | TITAN PHARMACEUTICALS INC | TTNP | Beebe Katherine COO | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-11 06:35 am | 2021-08-10 2031-02-10 | TITAN PHARMACEUTICALS INC | TTNP | Akers Joseph A Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-11 06:31 am | 2021-08-10 2031-02-10 | TITAN PHARMACEUTICALS INC | TTNP.OB | MACFARLANE M DAVID Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-11 06:29 am | 2021-08-10 2031-02-10 | TITAN PHARMACEUTICALS INC | TTNP | MCNAB JAMES R Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-11 06:26 am | N/A 2031-02-10 | TITAN PHARMACEUTICALS INC | TTNP | Rubin Marc Chairman | 150,000 | $0 | 150,000 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-07 4:20 pm | N/A 2029-06-05 | TITAN PHARMACEUTICALS INC | TTNP | Hallberg Dane See Remarks | 80,000 | $0 | 80,000 (Direct) | View |
| 2019-04-02 Option Award | 2019-04-03 4:30 pm | N/A 2029-04-02 | TITAN PHARMACEUTICALS INC | TTNP | Rubin Marc Chairman | 200,000 | $0 | 200,000 (Direct) | View |
| 2019-04-02 Option Award | 2019-04-03 4:30 pm | N/A 2029-04-02 | TITAN PHARMACEUTICALS INC | TTNP | BHONSLE SUNIL CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2019-02-19 Ownership | 2019-02-25 5:36 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | Beebe Katherine Chief Scientific Officer | 0 | $0 | 63,452 (Direct) | View |
| 2019-02-19 Ownership | 2019-02-25 5:35 pm | N/A 2028-10-01 | TITAN PHARMACEUTICALS INC | TTNP | Hallberg Dane See Remarks | 0 | $0 | 41,667 (Direct) | View |
| 2018-09-21 Option Award | 2018-09-25 7:09 pm | 2018-09-25 2023-09-25 | TITAN PHARMACEUTICALS INC | TTNP.OB | MACFARLANE M DAVID Director | 80,000 | $0 | 182,275 (Direct) | View |
| 2018-09-21 Option Award | 2018-09-25 7:06 pm | 2023-09-25 2023-09-25 | TITAN PHARMACEUTICALS INC | TTP | BHONSLE SUNIL See Remarks | 300,000 | $0 | 790,262 (Direct) | View |
| 2018-09-21 Option Award | 2018-09-25 7:04 pm | 2018-09-25 2023-09-25 | TITAN PHARMACEUTICALS INC | TTNP | MCNAB JAMES R Director | 200,000 | $0 | 500,000 (Direct) | View |
| 2018-09-21 Option Award | 2018-09-25 7:02 pm | 2018-09-25 2023-09-25 | TITAN PHARMACEUTICALS INC | TTNP | Rubin Marc Chairman | 400,000 | $0 | 956,317 (Direct) | View |
| 2018-09-21 Option Award | 2018-09-25 7:00 pm | 2018-09-25 2023-09-25 | TITAN PHARMACEUTICALS INC | TTNP | Akers Joseph A Director | 200,000 | $0 | 413,000 (Direct) | View |
| 2018-05-14 Ownership | 2018-05-23 3:43 pm | N/A N/A | TITAN PHARMACEUTICALS INC | TTNP | Recli Federico Seghi Director | 0 | $0 | 2,645,845 (Direct) | View |
| 2018-03-07 Option Award | 2018-03-09 4:37 pm | N/A 2028-03-07 | TITAN PHARMACEUTICALS INC | TTNP | BHONSLE SUNIL CEO | 170,000 | $0 | 170,000 (Direct) | View |
| 2018-03-07 Option Award | 2018-03-09 4:35 pm | N/A 2028-03-07 | TITAN PHARMACEUTICALS INC | TTNP | Rubin Marc Chairman | 170,000 | $0 | 170,000 (Direct) | View |